Occlusion tool software for pulmonary vein occlusion verification in atrial fibrillation cryoballoon ablation

Abstract Background Optimal pulmonary vein (PV) occlusion, usually verified with selective contrast injection, is mandatory to obtain an effective PV isolation during cryoballoon (CB) ablation. Aim of the study The purpose of this study was to verify the feasibility and the accuracy of a new dielect...

Full description

Bibliographic Details
Published in:Pacing and Clinical Electrophysiology
Main Authors: Cauti, Filippo Maria, Solimene, Francesco, Stabile, Giuseppe, Polselli, Marco, Schillaci, Vincenzo, Arestia, Alberto, Shopova, Gergana, Iaia, Luigi, Giannitti, Carlo Maria, Rossi, Pietro, Bianchi, Stefano
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2020
Subjects:
Cardiology and Cardiovascular Medicine
General Medicine
Arctic
Online Access:http://dx.doi.org/10.1111/pace.14130
https://onlinelibrary.wiley.com/doi/pdf/10.1111/pace.14130
https://onlinelibrary.wiley.com/doi/full-xml/10.1111/pace.14130
Description
Summary:Abstract Background Optimal pulmonary vein (PV) occlusion, usually verified with selective contrast injection, is mandatory to obtain an effective PV isolation during cryoballoon (CB) ablation. Aim of the study The purpose of this study was to verify the feasibility and the accuracy of a new dielectric sensing system in assessing PV occlusion during CB ablation in patients with atrial fibrillation (AF). Methods We enrolled 28 consecutive patients with paroxysmal or persistent AF. After transseptal access, a detailed image reconstruction of left atrium and PVs was achieved with an octapolar or decapolar mapping catheter (Achieve catheter, Medtronic Inc.) and KODEX‐EPD system (EPD Solutions, a Philips company). The degree of PV occlusion with the inflated Arctic Front Advance Cryoballoon (Medtronic Inc.) was verified using the new “occlusion tool” software module (EPD Solutions, a Philips company) and compared to an angiogram obtained with contrast medium injection in each PV. Results A total of 105 PV CB occlusion were tested. The new occlusion tool software module showed a 91% sensitivity and 76% specificity in assessing a complete PV occlusion verified with contrast medium injection. The positive predictive value was 80%, and the negative predictive value was 88.6%. Mean procedure time was 81 ± 17 minutes. Mean fluoroscopy time was 6 ± 2 minutes. No 30‐day complications were observed. Conclusion The new dielectric imaging system was able to assess the degree of PV occlusion during a CB ablation with good sensitivity and specificity.

Similar Items